The increased incidence of cancer and other infectious illnesses such as TB, meningococcal disease, and others is one of the primary factors behind the expansion of the next generation sequencing industry. DNA testing is becoming more popular as a consequence of advances in next-generation sequencing tools and technologies, faster results, and lower costs as compared to genotyping-based DNA microarrays. The storage and handling of massive data created by next generation sequencing, as well as its interpretation, are important constraints impeding the growth of the worldwide next generation sequencing industry. PerkinElmer, Inc., a global corporation focused on diagnostics, life science research, food, environmental, as well as industrial testing, announced the introduction of the research use only (RUO) BioQule NGS System on June 6, 2022, an automated benchtop remedy for next-generation sequencing (NGS) library preparation of as many as eight samples.
Coherent Market Insights mentions in its study that the global Next Generation Sequencing Market is estimated to be valued at US$ 12,870.5 million in 2022 and is expected to exhibit a CAGR of 18.3% during the forecast period (2022-2030).
Leading companies in the Next Generation Sequencing Industry:
1 Thermo Fisher Scientific
The companys Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. The company was incorporated in 1956 and is based in Waltham, Massachusetts. On December 8, 2021, thermos fisher Scientific has completed its acquisition of PPD, Inc., a leading global provider of clinical research services to the biopharma and biotech industry.
2. PerkinElmer Inc.
PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. PerkinElmer has made 28 acquisitions and 4 investments. The company has spent over USD 10.61B for the acquisitions. PerkinElmer has invested in multiple sectors such as Life Sciences Platforms and Tools, Genomics, Life Sciences Tech and more.
3. Agilent Technologies
Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California. Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. Agilent Technologies Inc) on March 2021 announced it has entered into a definitive agreement to acquire Resolution Bioscience Inc., a leader in the development and commercialization of next-generation sequencing (NGS)-based precision oncology solutions, with an aim to expand Agilents capabilities in NGS-based cancer diagnostics and provides the company with innovative technology to further serve the needs of the fast-growing precision medicine market.
4. BioMérieux SA
bioMerieux S.A. was founded in 1963 and is headquartered in Marcy Etoile, France. bioMerieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. bioMerieux has acquired 21 companies, including 3 in the 5 years.
5. F. Hoffmann-La Roche Ltd
The company was founded in 1896 and is headquartered in Basel, Switzerland. Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally.
6. QIAGEN
The company was founded in 1986 and is headquartered in Venlo, the Netherlands. On May 2022, Qiagen said on Wednesday that it has acquired a 96 percent stake in Blirt, a Gdansk, Poland-based manufacturer of recombinant enzymes for the life science industry. The addition of Blirt to Qiagen brings highly complementary capabilities that will create additional growth prospects for our enzymes and reagents business.
7. Illumina
The company was incorporated in 1998 and is based in San Diego, California. Illumina has acquired 28 companies. Its largest acquisition to date was in 2020, when it acquired GRAIL for $8.0B. Illumina has acquired in 9 different states in US, and 9 countries.
8. Oxford Nanopore Technologies plc
Oxford Nanopore Technologies plc develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules. Oxford Nanopore Technologies plc was incorporated in 2005 and is based in Oxford, the United Kingdom.
9. BGI Genomics Co.
BGI Genomics Co., Ltd. provides sequencing services and a portfolio of genetic tests for medical institutions, research institutions, and other public and private partners in China and internationally. The company offers DNA, RNA, and customized sequencing services; and non-invasive prenatal testing. BGI Genomics Co., Ltd. was founded in 1999 and is headquartered in Shenzhen, China.
*Definition- NGS is a high-throughput DNA sequencing method that isolates billions or millions of DNA strands and sequences them in parallel, producing greater output and eliminating the need for fragment-cloning processes.
